Related Experiment Video
Updated: Dec 24, 2025

06:54
Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion
Published on: June 15, 2019
6.3K
Heparan Sulfate in the Tumor Microenvironment.
Barbara Bartolini1, Elena Caravà1, Ilaria Caon1
1Department of Medicine and Surgery, University of Insubria, Varese, Italy.
Advances in Experimental Medicine and Biology
|April 9, 2020
Summary
The tumor microenvironment, regulated by extracellular matrix components like heparan sulfate (HS) and heparan sulfate proteoglycans (HSPGs), influences cancer progression. Targeting HS and HSPGs offers a novel therapeutic strategy for cancer treatment.
Area of Science:
- Biochemistry
- Cell Biology
- Oncology
Background:
- Tumor cell biology is critically dependent on the tumor microenvironment's composition and architecture.
- The extracellular matrix (ECM), comprising glycosaminoglycans, proteoglycans, and proteins, regulates growth factors and signaling molecules, influencing tumor fate.
- Heparan sulfate (HS) and heparan sulfate proteoglycans (HSPGs) are key ECM components that bind and modulate growth factors and cell receptors.
Purpose of the Study:
- To investigate the role of HS and HSPGs in regulating processes altered during tumor progression, such as cell adhesion, motility, and proliferation.
- To explore the potential of targeting HS structure and metabolism as a novel therapeutic approach for various cancer types.
Main Methods:
- Analysis of HS and HSPG expression and activity within the tumor microenvironment.
- Investigation of the impact of HS and HSPG modifications on tumor cell behavior.
- Evaluation of HS-targeting strategies in preclinical cancer models.
Main Results:
- Alterations in HS, HSPG, and their metabolic enzyme expression and activity were observed, leading to changes in the tumor microenvironment.
- HS binding partners critically modulate cell adhesion, motility, and proliferation, processes fundamental to tumor progression.
- Targeting HS structure and metabolism demonstrated potential in modulating tumor progression.
Conclusions:
- The tumor microenvironment, particularly the ECM components HS and HSPGs, plays a crucial role in regulating tumor cell behavior and fate.
- Modifications in HS and HSPG metabolism significantly alter the tumor microenvironment.
- Targeting HS and HSPGs presents a promising new avenue for cancer therapy.
Related Concept Videos
The Tumor Microenvironment
7.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.5K
Mitogens and the Cell Cycle
7.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.6K
Metastasis
6.3K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K
Tumor Progression
7.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.1K
Regulation of Hematopoietic Stem Cells
3.8K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.8K

